Literature DB >> 36180649

MRI correlates of motoneuron loss in SMA.

Alina Sprenger-Svačina1, Johannes Haensch1, Kilian Weiss2,3, Nils Große Hokamp2, David Maintz2, Marc Schlamann2, Gereon R Fink1,4, Natalie Schloss1, Kai Laukamp2, Gilbert Wunderlich1, Helmar C Lehmann5, Thorsten Lichtenstein2.   

Abstract

BACKGROUND: Magnetic resonance imaging (MRI) is currently explored as supplemental tool to monitor disease progression and treatment response in various neuromuscular disorders. We here assessed the utility of a multi-parametric magnetic resonance imaging (MRI) protocol including quantitative water T2 mapping, Dixon-based proton density fat fraction (PDFF) estimation and diffusion tensor imaging (DTI) to detect loss of spinal motor neurons and subsequent muscle damage in adult SMA patients.
METHODS: Sixteen SMA patients and 13 age-matched controls were enrolled in this prospective, longitudinal study. All participants underwent MRI imaging including measurements of Dixon-based PDFF and DTI of the sciatic nerve. SMA patients furthermore underwent measurements of muscle water T2 (T2w) of the biceps femoris muscle (BFM) and quadriceps femoris muscle (QFM). Ten participants returned for a second scan six months later. MRI parameter were correlated with clinical data. All patients were on nusinersen treatment.
RESULTS: There were significantly higher intramuscular fat fractions in the BFM and QFM of SMA patients compared to healthy controls at baseline and after 6 months. Furthermore, T2 values significantly correlated positively with intramuscular fat fractions. The Hammersmith functional motor scale significantly correlated with the QFM's intramuscular fat fractions. DTI scans of the sciatic nerve were not significantly different between the two groups.
CONCLUSION: This study demonstrates that, water T2 mapping and Dixon-based PDFF estimation may distinguish between adult SMA patients and controls, due to massive intramuscular fat accumulation in SMA. More extensive long-term studies are warranted to further evaluate these two modalities as surrogate markers in SMA patients during treatment.
© 2022. The Author(s).

Entities:  

Keywords:  DTI; Neuromuscular disease; Proton-density fat fraction; Spinal muscular atrophy; Water T 2 mapping

Year:  2022        PMID: 36180649     DOI: 10.1007/s00415-022-11326-1

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   6.682


  29 in total

1.  MRI patterns of muscle involvement in type 2 and 3 spinal muscular atrophy patients.

Authors:  Claudia Brogna; Lara Cristiano; Tommaso Verdolotti; Anna Pichiecchio; Claudia Cinnante; Valeria Sansone; Luca Maria Sconfienza; Angela Berardinelli; Matteo Garibaldi; Giovanni Antonini; Marika Pane; Maria Carmela Pera; Laura Antonaci; Luana Ficociello; Emilio Albamonte; Giorgio Tasca; Chiara Begliuomini; Tommaso Tartaglione; Lorenzo Maggi; Alessandra Govoni; Giacomo Comi; Cesare Colosimo; Eugenio Mercuri
Journal:  J Neurol       Date:  2019-11-27       Impact factor: 4.849

Review 2.  Diagnosis and management of spinal muscular atrophy: Part 1: Recommendations for diagnosis, rehabilitation, orthopedic and nutritional care.

Authors:  Eugenio Mercuri; Richard S Finkel; Francesco Muntoni; Brunhilde Wirth; Jacqueline Montes; Marion Main; Elena S Mazzone; Michael Vitale; Brian Snyder; Susana Quijano-Roy; Enrico Bertini; Rebecca Hurst Davis; Oscar H Meyer; Anita K Simonds; Mary K Schroth; Robert J Graham; Janbernd Kirschner; Susan T Iannaccone; Thomas O Crawford; Simon Woods; Ying Qian; Thomas Sejersen
Journal:  Neuromuscul Disord       Date:  2017-11-23       Impact factor: 4.296

3.  Quantifying disease activity in fatty-infiltrated skeletal muscle by IDEAL-CPMG in Duchenne muscular dystrophy.

Authors:  Ami Mankodi; Courtney A Bishop; Sungyoung Auh; Rexford D Newbould; Kenneth H Fischbeck; Robert L Janiczek
Journal:  Neuromuscul Disord       Date:  2016-07-28       Impact factor: 4.296

4.  Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy.

Authors:  Richard S Finkel; Eugenio Mercuri; Basil T Darras; Anne M Connolly; Nancy L Kuntz; Janbernd Kirschner; Claudia A Chiriboga; Kayoko Saito; Laurent Servais; Eduardo Tizzano; Haluk Topaloglu; Már Tulinius; Jacqueline Montes; Allan M Glanzman; Kathie Bishop; Z John Zhong; Sarah Gheuens; C Frank Bennett; Eugene Schneider; Wildon Farwell; Darryl C De Vivo
Journal:  N Engl J Med       Date:  2017-11-02       Impact factor: 91.245

5.  Minimal clinically important differences in functional motor scores in adults with spinal muscular atrophy.

Authors:  B Stolte; J-M Bois; S Bolz; K Kizina; A Totzeck; M Schlag; C Kleinschnitz; T Hagenacker
Journal:  Eur J Neurol       Date:  2020-09-06       Impact factor: 6.089

6.  Correction: Dignity and Distress towards the End of Life across Four Non-Cancer Populations.

Authors:  Harvey Max Chochinov; Wendy Johnston; Susan E McClement; Thomas F Hack; Brenden Dufault; Murray Enns; Genevieve Thompson; Mike Harlos; Ronald W Damant; Clare D Ramsey; Sara Davison; James Zacharias; Doris Milke; David Strang; Heather J Campbell-Enns; Maia S Kredentsere
Journal:  PLoS One       Date:  2017-11-09       Impact factor: 3.240

7.  Longitudinal characterization of biomarkers for spinal muscular atrophy.

Authors:  Ulrike Bonati; Štefan Holiga; Nicole Hellbach; Céline Risterucci; Tobias Bergauer; Wakana Tang; Patricia Hafner; Alain Thoeni; Oliver Bieri; Irene Gerlach; Anne Marquet; Omar Khwaja; Fabio Sambataro; Alessandro Bertolino; Juergen Dukart; Arne Fischmann; Dirk Fischer; Christian Czech
Journal:  Ann Clin Transl Neurol       Date:  2017-04-11       Impact factor: 4.511

8.  Response to: Alfred Sandrock, Wildon Farwell. Letter to the Editor, Comparisons Between Separately Conducted Clinical Trials: Letter to the Editor Regarding Dabbous O, Maru B, Jansen JP, Lorenzi M, Cloutier M, Guérin A, et al. Adv Ther (2019) 36(5):1164-76. doi:10.1007/s12325-019-00923-8.

Authors:  Omar Dabbous; Benit Maru; Jeroen P Jansen; Maria Lorenzi; Martin Cloutier; Annie Guérin; Irina Pivneva; Eric Q Wu; Ramesh Arjunji; Douglas Feltner; Douglas M Sproule
Journal:  Adv Ther       Date:  2019-09-11       Impact factor: 3.845

9.  Prospective and longitudinal natural history study of patients with Type 2 and 3 spinal muscular atrophy: Baseline data NatHis-SMA study.

Authors:  Aurélie Chabanon; Andreea Mihaela Seferian; Aurore Daron; Yann Péréon; Claude Cances; Carole Vuillerot; Liesbeth De Waele; Jean-Marie Cuisset; Vincent Laugel; Ulrike Schara; Teresa Gidaro; Stéphanie Gilabert; Jean-Yves Hogrel; Pierre-Yves Baudin; Pierre Carlier; Emmanuel Fournier; Linda Pax Lowes; Nicole Hellbach; Timothy Seabrook; Elie Toledano; Mélanie Annoussamy; Laurent Servais
Journal:  PLoS One       Date:  2018-07-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.